Remove category
article thumbnail

News from the Consumer Technology Association and Withings Further Demonstrates Private Sector’s Role in the Pandemic and Public Health

Health Populi

Twelve years ago, when I began to attend CES, digital health was a nascent category featured with products featured in a couple of aisles in exhibit booths then dominated by Fitbit, Nike and UnderArmour. The company’s Core ScanWatch was a CES 2020 Honoree in the category of Fitness/Sports and Wearable Technologies.

article thumbnail

Unpacking Averages: Assessing the Racial Composition of Drug Clinical Trial Subjects

Health Law Advisor

The United States Food and Drug Administration (FDA) for many years has been trying to increase the participation of minorities in clinical trials to help ensure that regulated products are tested and labeled in an appropriate cross-section of Americans. National Library of Medicine, with support from FDA.

FDA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

FDA approves sleep apnea tech from EnsoData, Samsung

Healthcare It News

EnsoData announced Tuesday that it has received FDA 510(k) clearance for an AI algorithm called EnsoSleep to support the diagnosis of sleep disorders using any FDA-cleared pulse oximeter, which measures the saturation of oxygen carried in red blood cells. between 2008 and 2021, CBS News said in a story on how to apply.

FDA 269
article thumbnail

Not the Best Wisconsin Law Decision We’ve Ever Seen

Drug & Device Law

The Wisconsin guest post let us know about a pending decision that – we all hoped – would take that state out of the “no state appellate precedent” category altogether: Wisconsin has recently made it to the red zone, and may soon cross the goal line, with the Wisconsin Court of Appeals’ forthcoming decision in Rennick v. 2008); Herzog v.

FDA 59
article thumbnail

The Goose And Gander Of Buying The Science

Drug & Device Law

It has also been the case for a long time that the use of citizen’s petitions to FDA has been a tool by the plaintiff bar to shape, and sometimes sidestep, the science. ( 2008) (cited in Paraquat, 2023 WL 8372819, * 3 n.3). See, e.g. , here.) See, e.g. , here.) Probably not from the journal that published it.

FDA 52
article thumbnail

Logical Contradiction Doctrine:  Buckman for Textualists

Drug & Device Law

440 (2008) Buckman was not cited at all in the Merck Sharp & Dohme Corp. 470 (1996), was decided – removing express preemption as a defense for manufacturers of §510(k) products So defendants moved on fraud on the FDA under an implied preemption theory and won. Plaintiffs Legal Committee , 531 U.S. Kent , 552 U.S. Lohr , 518 U.S.

FDA 72
article thumbnail

Thinking About the FDA’s Alternative Summary Reporting Program

Drug & Device Law

He came across several preemption decisions involving defendants who employed the FDA’s “alternative summary reporting” (“ASR”) system that the agency operated for about 20 years, “from 1997 through June 2019.” without adversely affecting FDA’s ability to monitor and react to such events.

FDA 59